4-(TRIFLUOROMETHYL)BENZYL BROMIDE | CAS:402-49-3

We serve 4-(TRIFLUOROMETHYL)BENZYL BROMIDE CAS:402-49-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
4-(TRIFLUOROMETHYL)BENZYL BROMIDE

Chemical Name:4-(TRIFLUOROMETHYL)BENZYL BROMIDE
CAS.NO:402-49-3
Synonyms:α-Bromo-α',α',α'-trifluoro-p-xylene; 
1-(bromomethyl)-4-(trifluoromethyl)benzene; 
4-(TrifluoroMethyl)benzyl BroMide; 
4-(Bromomethyl)benzotrifluoride; 
alpha‘-Bromo-alpha,alpha,alpha-trifluoro-p-xylene;
Molecular Formula:C8H6BrF3
Molecular Weight:239.03200
 
Physical and Chemical Properties:
Density:1.546;
Melting point:29-33oC;
Boiling point:65-69oC;
Flash point:192oF;
Index of Refraction:1.484;
 
Specification:
Appearance:White to light yellow low melting solid
Purity(GC):≥99.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate for organic synthesis



Contact us for information like 4-(TRIFLUOROMETHYL)BENZYL BROMIDE chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,alpha‘-Bromo-alpha,alpha,alpha-trifluoro-p-xylene physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-(TRIFLUOROMETHYL)BENZYL BROMIDE Use and application,4-(TrifluoroMethyl)benzyl BroMide technical grade,usp/ep/jp grade.


Related News: First of all, as an API manufacturer we think of how to make a chemical compound which becomes an API in the laboratory.bromo(trimethyl)silane manufacturer First of all, as an API manufacturer we think of how to make a chemical compound which becomes an API in the laboratory.1-butyl-4-(4-iodophenyl)benzene supplier In the context of increasingly tight global productive capacity cooperation in the pharmaceutical industry, some multinational pharmaceutical companies have chosen to abandon their original full industrial chain model and shift their focus to market operations. R & D, clinical, and production links reduce costs through outsourcing. Patented APIs came into being.4-Hydroxybenzothioamide vendor In the context of increasingly tight global productive capacity cooperation in the pharmaceutical industry, some multinational pharmaceutical companies have chosen to abandon their original full industrial chain model and shift their focus to market operations. R & D, clinical, and production links reduce costs through outsourcing. Patented APIs came into being.In the context of increasingly tight global productive capacity cooperation in the pharmaceutical industry, some multinational pharmaceutical companies have chosen to abandon their original full industrial chain model and shift their focus to market operations. R & D, clinical, and production links reduce costs through outsourcing. Patented APIs came into being.